An Israeli company has engineered a type of drug for dealing with pain that allows patients to have a clear head.

A special plantation grows in the hills of Galilee. Heavily guarded and under the protection of a 1993 law that permits medical marijuana in Israel, a crop of modified cannabis has been developed by Tikun Olam, the first and largest cultivator of the plant in the country. Their new strain, called Avidekel, retains the beneficial anti-pain and anti-inflammatory properties of cannabis without the sometimes undesirable intoxicating effects.

This innovation in botany has significant medical application. Many people who could benefit from using medical marijuana are turned off by the high that THC, one of the plant's many constituent chemicals, gives users. Until now it was difficult to isolate CBD, the plant's medically beneficial substance. What Tikun Olam has done is to engineer a plant to do the work for them: Avidekel grows to contain over 15% CBD, with only trace amounts of THC.

$15 provides access to this article and every case-study, interview, and analysis piece that we publish for the next 30 days. Our Premium Subscription also provides access to a database of over 100,000 articles on innovation in brand, customer, and retail experience.
Already a subscriber? Log in